Adaptive radiation therapy (RT) is an innovative treatment approach that is entering radiation oncology practice for the treatment of a variety of malignancies.

Palliative radiation therapy is underutilized across a variety of clinical settings, with reported disparities in palliative radiation therapy administration based on age, race, ethnicity, socioeconomic status and geography.

This activity is dedicated to unraveling the emerging field of focal therapies in oncology, with a specific focus on histotripsy, high-intensity focused ultrasound (HIFU) and electroporation.

This session highlights five of the most clinically relevant abstracts within the Central Nervous System track of the 2024 ASTRO Annual Meeting scientific program.

This activity will evaluate contouring of Upper GI tumors and include a discussion about esophageal cancers, pancreatic, and hepatobiliary cancers.

Cases Covered

Case 1: HCC

Case 2:Pancreatic Cancer

Case 3: GEJ Adenocarcinoma

Although immunotherapy has revolutionized the treatment of cancer, the translation of immunotherapy-radiotherapy (IT-RT) combinations into the clinic has proven challenging.

Normal tissue dose-volume constraints are commonly used for lymphoma radiation therapy (RT) planning.

In the United States, the conventional approach to treating locally advanced rectal cancer has traditionally combined preoperative chemoradiotherapy, total mesorectal excision and adjuvant chemotherapy.

Pancreato-biliary cancers, mainly pancreatic cancer and extrahepatic cholangiocarcinoma, are almost uniformly fatal malignancies with increasing incidence and poor prognosis even when diagnosed in the early stages of the disease.

This activity focuses on evidence-based breast cancer contouring practices.

Pages

Subscribe to RSS - Sessions onDemand